Litcius/Paper detail

Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis

Maxim Grymonprez, Tine L. De Backer, Stéphane Steurbaut, Koen Boussery, Lies Lahousse

2021Cardiovascular Drugs and Therapy21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVitamin K antagonistInternal medicineStroke (engine)Atrial fibrillationRelative riskWarfarinPopulationBody mass indexUnderweightGastroenterologyConfidence intervalOverweightEnvironmental healthEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesVitamin K Research StudiesVenous Thromboembolism Diagnosis and Management
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis | Litcius